Anixa Biosciences Inc (ANIX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2020-10-31, while the company's latest annual report covers the year ended 2025-10-31. Its later filings do not report this line under the concept TickerFacts maps.
$15.8K
Year ended 2020-10-31
-19.4%
3-year compound annual growth
-22.0%
5-year compound annual growth
+22.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2020-10-31 | $15.8K | -91.0% | 2022-01-04, From 2019-11-01 |
| 2019-10-31 | $175.5K | +356.9% | 2021-01-07, From 2018-11-01 |
| 2018-10-31 | $38.4K | +27.2% | 2020-01-09, From 2017-11-01 |
| 2017-10-31 | $30.2K | -79.4% | 2019-01-11, From 2016-11-01 |
| 2016-10-31 | $146.5K | +167.5% | 2018-01-09, From 2015-11-01 |
| 2015-10-31 | $54.8K | +719.5% | 2016-12-08, From 2014-11-01 |
| 2014-10-31 | $6.7K | n/a | 2015-12-23, From 2013-11-01 |
| No annual figure between 2012-10-31 and 2014-10-31. | |||
| 2012-10-31 | $1.6K | -82.3% | 2013-01-29, From 2011-11-01 |
| 2011-10-31 | $9.0K | +336.3% | 2013-01-29, From 2010-11-01 |
| 2010-10-31 | $2.1K | n/a | 2012-01-30, From 2009-11-01 |